Medtech stocks flipped the script last month, having underperformed the S&P 500 by 4% after out-performing the index by nearly 5% during the 1st quarter, according to a Morgan Stanley analysis.
The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.
The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.
Zimmer Holdings, Edwards Lifesciences, Hansen Medical Inc., Intuitive Surgical Inc., Johnson & Johnson, Medtronic, Morgan Stanley, Accuray Inc.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1q76KeZ
Cap comentari:
Publica un comentari a l'entrada